Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Current Assets (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Current Assets for 4 consecutive years, with $6.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets fell 8.44% to $6.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.3 million, a 8.44% decrease, with the full-year FY2024 number at $5.4 million, down 25.63% from a year prior.
  • Current Assets was $6.3 million for Q3 2025 at 60 Degrees Pharmaceuticals, up from $3.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $8.9 million in Q3 2023 to a low of $1.1 million in Q4 2022.
  • A 4-year average of $5.7 million and a median of $5.7 million in 2023 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: soared 559.01% in 2023, then plummeted 33.69% in 2024.
  • 60 Degrees Pharmaceuticals' Current Assets stood at $1.1 million in 2022, then skyrocketed by 559.01% to $7.2 million in 2023, then dropped by 25.63% to $5.4 million in 2024, then rose by 17.13% to $6.3 million in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Current Assets are $6.3 million (Q3 2025), $3.8 million (Q2 2025), and $5.7 million (Q1 2025).